PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 926-935

  de Graaf, Natascha ^a   van Helden, Mary J G ^a   Textoris Taube, Kathrin ^b   Chiba, Tomoki ^c   Topham, David J ^d   Kloetzel, Peter Michael ^b   Zaiss, Dietmar M W ^a   Sijts, Alice J A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Antigen processing; CD8+ T cell; Immunoproteasome; MHC class I; PA28

Indexed keywords

CELL PROTEIN; GAMMA INTERFERON; LARGE MULTIFUNCTIONAL PEPTIDASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDASE; PROTEASOME; PROTEIN MECL 1; PROTEIN PA28; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 79953035505     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041040     Document Type: Article

References (48)

1. Deol, P., Zaiss, D. M., Monaco, J. J. and Sijts, A. J., Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J. Immunol. 2007. 178: 7557-7562.
2. Probst, H. C., Tschannen, K., Gallimore, A., Martinic, M., Basler, M., Dumrese, T., Jones, E. and van den Broek, M. F., Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 2003. 171: 5415-5422.
3. Deng, Y., Yewdell, J. W., Eisenlohr, L. C. and Bennink, J. R., MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 1997. 158: 1507-1515.
4. Chen, W., Norbury, C. C., Cho, Y., Yewdell, J. W. and Bennink, J. R., Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 2001. 193: 1319-1326.
5. Sijts, A. J., Standera, S., Toes, R. E., Ruppert, T., Beekman, N. J., van Veelen, P. A., Ossendorp, F. A. et al., MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J. Immunol. 2000. 164: 4500-4506.
6. van Hall, T., Sijts, A., Camps, M., Offringa, R., Melief, C., Kloetzel, P. M. and Ossendorp, F., Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J. Exp. Med. 2000. 192: 483-494.
7. Schwarz, K., van Den Broek, M., Kostka, S., Kraft, R., Soza, A., Schmidtke, G., Kloetzel, P. M. and Groettrup, M., Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J. Immunol. 2000. 165: 768-778.
8. Coux, O., Tanaka, K. and Goldberg, A. L., Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 1996. 65: 801-847.
9. Shin, E. C., Seifert, U., Kato, T., Rice, C. M., Feinstone, S. M., Kloetzel, P. M. and Rehermann, B., Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J. Clin. Invest. 2006. 116: 3006-3014.
10. Hallermalm, K., Seki, K., Wei, C., Castelli, C., Rivoltini, L., Kiessling, R. and Levitskaya, J., Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 2001. 98: 1108-1115.
11. Nandi, D., Jiang, H. and Monaco, J. J., Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit. J. Immunol. 1996. 156: 2361-2364.
12. Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U. H. and Kloetzel, P. M., Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 1994. 179: 901-909.
13. Realini, C., Dubiel, W., Pratt, G., Ferrell, K. and Rechsteiner, M., Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem. 1994. 269: 20727-20732.
14. Ossendorp, F., Fu, N., Camps, M., Granucci, F., Gobin, S. J., van den Elsen, P. J., Schuurhuis, D. et al., Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J. Immunol. 2005. 174: 7815-7822.
15. Soza, A., Knuehl, C., Groettrup, M., Henklein, P., Tanaka, K. and Kloetzel, P. M., Expression and subcellular localization of mouse 20S proteasome activator complex PA28. FEBS Lett. 1997. 413: 27-34.
16. Macagno, A., Gilliet, M., Sallusto, F., Lanzavecchia, A., Nestle, F. O. and Groettrup, M., Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 1999. 29: 4037-4042.
17. Sijts, A., Sun, Y., Janek, K., Kral, S., Paschen, A., Schadendorf, D. and Kloetzel, P. M., The role of the proteasome activator PA28 in MHC class I antigen processing. Mol. Immunol. 2002. 39: 165-169.
18. Fehling, H. J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U. and von Boehmer, H., MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994. 265: 1234-1237.
19. Sijts, A., Zaiss, D. and Kloetzel, P. M., The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design. Curr. Mol. Med. 2001. 1: 665-676.
20. Nussbaum, A. K., Rodriguez-Carreno, M. P., Benning, N., Botten, J. and Whitton, J. L., Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J. Immunol. 2005. 175: 1153-1160.
21. Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schroter, F., Prozorovski, T. et al., Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 2010. 142: 613-624.
22. Zhang, Z., Krutchinsky, A., Endicott, S., Realini, C., Rechsteiner, M. and Standing, K. G., Proteasome activator 11S REG or PA28: Recombinant REG alpha/REG beta hetero-oligomers are heptamers. Biochemistry 1999. 38: 5651-5658.
23. Dick, T. P., Ruppert, T., Groettrup, M., Kloetzel, P. M., Kuehn, L., Koszinowski, U. H., Stevanovic, S. et al., Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 1996. 86: 253-262.
24. Shimbara, N., Nakajima, H., Tanahashi, N., Ogawa, K., Niwa, S., Uenaka, A., Nakayama, E. and Tanaka, K., Double-cleavage production of the CTL epitope by proteasomes and PA28: Role of the flanking region. Genes Cells 1997. 2: 785-800.
25. Murata, S., Udono, H., Tanahashi, N., Hamada, N., Watanabe, K., Adachi, K., Yamano, T. et al., Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J. 2001. 20: 5898-5907.
26. Yamano, T., Sugahara, H., Mizukami, S., Murata, S., Chiba, T., Tanaka, K., Yui, K. and Udono, H., Allele-selective effect of PA28 in MHC class I antigen processing. J. Immunol. 2008. 181: 1655-1664.
27. Yamano, T., Murata, S., Shimbara, N., Tanaka, N., Chiba, T., Tanaka, K., Yui, K. and Udono, H., Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing. J. Exp. Med. 2002. 196: 185-196.
28. Gonciarz-Swiatek, M. and Rechsteiner, M., Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL. Mol. Immunol. 2006. 43: 1993-2001.
29. Caudill, C. M., Jayarapu, K., Elenich, L., Monaco, J. J., Colbert, R. A. and Griffin, T. A., T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 2006. 176: 4075-4082.
30. Sun, Y., Sijts, A. J., Song, M., Janek, K., Nussbaum, A. K., Kral, S., Schirle, M. et al., Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Cancer Res. 2002. 62: 2875-2882.
31. Kuckelkorn, U., Ferreira, E. A., Drung, I., Liewer, U., Kloetzel, P. M. and Theobald, M., The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context. Eur. J. Immunol. 2002. 32: 1368-1375.
32. Sijts, A. J., Ruppert, T., Rehermann, B., Schmidt, M., Koszinowski, U. and Kloetzel, P. M., Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 2000. 191: 503-514.
33. Toes, R. E., Nussbaum, A. K., Degermann, S., Schirle, M., Emmerich, N. P., Kraft, M., Laplace, C. et al., Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 2001. 194: 1-12.
34. De, M., Jayarapu, K., Elenich, L., Monaco, J. J., Colbert, R. A. and Griffin, T. A., Beta 2 subunit propeptides influence cooperative proteasome assembly. J. Biol. Chem. 2003. 278: 6153-6159.
35. Zaiss, D. M., de Graaf, N. and Sijts, A. J., The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Infect. Immun. 2008. 76: 1207-1213.
36. Basler, M., Moebius, J., Elenich, L., Groettrup, M. and Monaco, J. J., An altered T cell repertoire in MECL-1-deficient mice. J. Immunol. 2006. 176: 6665-6672.
37. -/- mice. Science 1999. 286: 2162-2165.
38. + T cells. J. Immunol. 2006. 177: 6238-6244.
39. Khan, S., van den Broek, M., Schwarz, K., de Giuli, R., Diener, P. A. and Groettrup, M., Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 2001. 167: 6859-6868.
40. + T cell responses. J. Immunol. 2006. 177: 7680-7688.
41. Basler, M., Youhnovski, N., Van Den Broek, M., Przybylski, M. and Groettrup, M., Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J. Immunol. 2004. 173: 3925-3934.
42. Foulds, K. E., Zenewicz, L. A., Shedlock, D. J., Jiang, J., Troy, A. E. and Shen, H., Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 2002. 168: 1528-1532.
43. Van Kaer, L., Ashton-Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K. L., Goldberg, A. L. et al., Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994. 1: 533-541.
44. Griffin, T. A., Nandi, D., Cruz, M., Fehling, H. J., Kaer, L. V., Monaco, J. J. and Colbert, R. A., Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 1998. 187: 97-104.
45. Niedermann, G., Grimm, R., Geier, E., Maurer, M., Realini, C., Gartmann, C., Soll, J. et al., Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J. Exp. Med. 1997. 186: 209-220.
46. Kunisawa, J. and Shastri, N., Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006. 24: 523-534.
47. Srivastava, P. K., Udono, H., Blachere, N. E. and Li, Z., Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994. 39: 93-98.
48. Pickering, A. M., Koop, A. L., Teoh, C. Y., Ermak, G., Grune, T. and Davies, K. J. A., The immunoproteasome, the 20S proteasome and PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem. J. 2010. 432: 585-594.